Integrated Bioinformatics Analysis Exhibits Pivotal Exercise-Induced Genes and Corresponding Pathways in Malignant Melanoma

Overview

Journal Front Genet

Date 2021 Mar 8

PMID 33679872

Citations 6

Authors

Jun Zhu

Suyu Hao

Xinyue Zhang

Jingyue Qiu

Qin Xuan

Liping Ye

Affiliations

Soon will be listed here.

Abstract

Malignant melanoma represents a sort of neoplasm deriving from melanocytes or cells developing from melanocytes. The balance of energy and energy-associated body composition and body mass index could be altered by exercise, thereby directly affecting the microenvironment of neoplasm. However, few studies have examined the mechanism of genes induced by exercise and the pathways involved in melanoma. This study used three separate datasets to perform comprehensive bioinformatics analysis and then screened the probable genes and pathways in the process of exercise-promoted melanoma. In total, 1,627 differentially expressed genes (DEGs) induced by exercise were recognized. All selected genes were largely enriched in NF-kappa B, Chemokine signaling pathways, and the immune response after gene set enrichment analysis. The protein-protein interaction network was applied to excavate DEGs and identified the most relevant and pivotal genes. The top 6 hub genes (Itgb2, Wdfy4, Itgam, Cybb, Mmp2, and Parp14) were identified, and importantly, 5 hub genes (Itgb2, Wdfy4, Itgam, Cybb, and Parp14) were related to weak disease-free survival and overall survival (OS). In conclusion, our findings demonstrate the prognostic value of exercise-induced genes and uncovered the pathways of these genes in melanoma, implying that these genes might act as prognostic biomarkers for melanoma.

Citing Articles

Comprehensive analysis of single cell and bulk RNA sequencing reveals the heterogeneity of melanoma tumor microenvironment and predicts the response of immunotherapy.

Zhang Y, Zhang C, He J, Lai G, Li W, Zeng H Inflamm Res. 2024; 73(8):1393-1409.

PMID: 38896289 DOI: 10.1007/s00011-024-01905-5.

Impact of Physical Exercise on Melanoma Hallmarks: Current Status of Preclinical and Clinical Research.

Ceci C, Garcia-Chico C, Atzori M, Lacal P, Lista S, Santos-Lozano A J Cancer. 2024; 15(1):1-19.

PMID: 38164270 PMC: 10751671. DOI: 10.7150/jca.88559.

Ferroptosis and WDFY4 as novel targets for immunotherapy of lung adenocarcinoma.

Huang L, Zhong L, Cheng R, Chang L, Qin M, Liang H Aging (Albany NY). 2023; 15(18):9676-9694.

PMID: 37728413 PMC: 10564425. DOI: 10.18632/aging.205042.

Identification and validation of a ferroptosis-related gene signature for predicting survival in skin cutaneous melanoma.

Ping S, Wang S, Zhao Y, He J, Li G, Li D Cancer Med. 2022; 11(18):3529-3541.

PMID: 35373463 PMC: 9487883. DOI: 10.1002/cam4.4706.

Development and Validation of an IL6/JAK/STAT3-Related Gene Signature to Predict Overall Survival in Clear Cell Renal Cell Carcinoma.

Zhan C, Xu C, Chen J, Shen C, Li J, Wang Z Front Cell Dev Biol. 2021; 9:686907.

PMID: 34660570 PMC: 8511427. DOI: 10.3389/fcell.2021.686907.

References

Selvaraj G, Kaliamurthi S, Kaushik A, Khan A, Wei Y, Cho W . Identification of target gene and prognostic evaluation for lung adenocarcinoma using gene expression meta-analysis, network analysis and neural network algorithms. J Biomed Inform. 2018; 86:120-134. DOI: 10.1016/j.jbi.2018.09.004. View

Barbero G, Castro M, Villanueva M, Quezada M, Fernandez N, DeMorrow S . An Autocrine Wnt5a Loop Promotes NF-κB Pathway Activation and Cytokine/Chemokine Secretion in Melanoma. Cells. 2019; 8(9). PMC: 6770184. DOI: 10.3390/cells8091060. View

Young C . Solar ultraviolet radiation and skin cancer. Occup Med (Lond). 2009; 59(2):82-8. DOI: 10.1093/occmed/kqn170. View

Yao N, Chen Q, Shi W, Tang L, Fu Y . PARP14 promotes the proliferation and gemcitabine chemoresistance of pancreatic cancer cells through activation of NF-κB pathway. Mol Carcinog. 2019; 58(7):1291-1302. DOI: 10.1002/mc.23011. View

Zhang X, Ashcraft K, Betof Warner A, Nair S, Dewhirst M . Can Exercise-Induced Modulation of the Tumor Physiologic Microenvironment Improve Antitumor Immunity?. Cancer Res. 2019; 79(10):2447-2456. PMC: 7474542. DOI: 10.1158/0008-5472.CAN-18-2468. View

Courneya K . Exercise in cancer survivors: an overview of research. Med Sci Sports Exerc. 2003; 35(11):1846-52. DOI: 10.1249/01.MSS.0000093622.41587.B6. View

Precazzini F, Pancher M, Gatto P, Tushe A, Adami V, Anelli V . Automated in vivo screen in zebrafish identifies Clotrimazole as targeting a metabolic vulnerability in a melanoma model. Dev Biol. 2019; 457(2):215-225. DOI: 10.1016/j.ydbio.2019.04.005. View

Zhou W, Hoon D, Huang S, Fujii S, Hashimoto K, Morishita R . RNA melanoma vaccine: induction of antitumor immunity by human glycoprotein 100 mRNA immunization. Hum Gene Ther. 1999; 10(16):2719-24. DOI: 10.1089/10430349950016762. View

Dos Santos C, Diniz V, Bachi A, Dos Santos de Oliveira L, Ghazal T, Passos M . Moderate physical exercise improves lymphocyte function in melanoma-bearing mice on a high-fat diet. Nutr Metab (Lond). 2019; 16:63. PMC: 6739998. DOI: 10.1186/s12986-019-0394-z. View

10.

Wu X, Sui Z, Zhang H, Wang Y, Yu Z . Integrated Analysis of lncRNA-Mediated ceRNA Network in Lung Adenocarcinoma. Front Oncol. 2020; 10:554759. PMC: 7523091. DOI: 10.3389/fonc.2020.554759. View

11.

de Oliveira R, Landman G, Locatelli D, Muzy G, Moraes A, Paschoal F . Pigmented epithelioid melanocytoma: A case report. J Cutan Pathol. 2020; 47(2):109-112. DOI: 10.1111/cup.13584. View

12.

Harvie M, Howell A, Thatcher N, Baildam A, Campbell I . Energy balance in patients with advanced NSCLC, metastatic melanoma and metastatic breast cancer receiving chemotherapy--a longitudinal study. Br J Cancer. 2005; 92(4):673-80. PMC: 2361878. DOI: 10.1038/sj.bjc.6602357. View

13.

Phillips T, Fadia M, Lea-Henry T, Smiles J, Walters G, Jiang S . MMP2 and MMP9 associate with crescentic glomerulonephritis. Clin Kidney J. 2017; 10(2):215-220. PMC: 5455255. DOI: 10.1093/ckj/sfw111. View

14.

Lazennec G, Richmond A . Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med. 2010; 16(3):133-44. PMC: 2840699. DOI: 10.1016/j.molmed.2010.01.003. View

15.

Cardamone G, Paraboschi E, Solda G, Duga S, Saarela J, Asselta R . Genetic Association and Altered Gene Expression of in Multiple Sclerosis Patients. Biomedicines. 2018; 6(4). PMC: 6315774. DOI: 10.3390/biomedicines6040117. View

16.

Postow M, Hamid O, Carvajal R . Mucosal melanoma: pathogenesis, clinical behavior, and management. Curr Oncol Rep. 2012; 14(5):441-8. DOI: 10.1007/s11912-012-0244-x. View

17.

Liang B, Li C, Zhao J . Identification of key pathways and genes in colorectal cancer using bioinformatics analysis. Med Oncol. 2016; 33(10):111. DOI: 10.1007/s12032-016-0829-6. View

18.

Khan A, Ali A, Junaid M, Liu C, Kaushik A, Cho W . Identification of novel drug targets for diamond-blackfan anemia based on RPS19 gene mutation using protein-protein interaction network. BMC Syst Biol. 2018; 12(Suppl 4):39. PMC: 5998885. DOI: 10.1186/s12918-018-0563-0. View

19.

Xu X, Yu J, Zhang H, Sun M, Gu J, Du X . Methylation profile of the promoter CpG islands of 31 genes that may contribute to colorectal carcinogenesis. World J Gastroenterol. 2004; 10(23):3441-54. PMC: 4576225. DOI: 10.3748/wjg.v10.i23.3441. View

20.

Qin W, Wu H, Cao L, Li H, He C, Zhao D . Research Progress on PARP14 as a Drug Target. Front Pharmacol. 2019; 10:172. PMC: 6411704. DOI: 10.3389/fphar.2019.00172. View